• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受初级 HIV 护理的 HIV 感染者中,与医疗记录相比,自我报告当前和既往抗逆转录病毒药物使用情况。

Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care.

机构信息

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):432-9. doi: 10.1002/pds.2096. Epub 2011 Feb 3.

DOI:10.1002/pds.2096
PMID:21294218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3118653/
Abstract

OBJECTIVE

Patient antiretroviral (ARV) therapy knowledge is essential for regimen adherence, successful therapeutic response, and minimization of resistance evolution. Moreover, a complete and accurate patient ARV history is needed to construct efficacious and tolerable future regimens. In this study we assessed the ability of HIV-infected patients receiving care in a university infectious diseases clinic to accurately recall current and past ARVs.

METHODS

A convenience sample (n = 205) of UNC HIV Clinical Cohort participants (n = 1840) completed a comprehensive in-person interview. Patients were asked about current and ever ARV use and were provided proprietary and generic ARV names and photographs. Self-reported sensitivity for current and ever ARV use (proportion that correctly identified all recorded ARVs), was calculated using the medical record as the gold standard.

RESULTS

One hundred and eighty-five patients had received ARVs at some point after enrollment in the cohort study (ever users). For current ARV use (n = 138), self-reported sensitivity was 63% (95% CI: 54-71). For ever use (n = 185), sensitivity was 18% (95% CI: 13-24).

CONCLUSION

Self-reported cumulative ARV use is not accurate. Since HIV-infected patients are prescribed a number of medications over their treatment course, it is necessary to develop new medication reconciliation techniques that are not dependent on patient memory or knowledge in order to improve patient outcomes.

摘要

目的

患者抗逆转录病毒(ARV)治疗知识对于方案依从性、治疗成功和耐药性进化最小化至关重要。此外,需要完整、准确的患者 ARV 病史来构建有效的、可耐受的未来方案。在这项研究中,我们评估了在大学传染病诊所接受治疗的 HIV 感染患者准确回忆当前和既往 ARV 的能力。

方法

UNC HIV 临床队列研究的便利样本(n=205)(n=1840)完成了全面的面对面访谈。患者被问及当前和既往的 ARV 使用情况,并提供了专有和通用的 ARV 名称和照片。使用病历作为金标准,根据自我报告的当前和既往 ARV 使用情况(正确识别所有记录的 ARV 的比例)计算敏感性。

结果

185 名患者在队列研究入组后曾接受过 ARV 治疗(既往使用者)。对于当前 ARV 使用(n=138),自我报告的敏感性为 63%(95%CI:54-71)。对于既往使用(n=185),敏感性为 18%(95%CI:13-24)。

结论

自我报告的累积 ARV 使用情况不准确。由于 HIV 感染患者在治疗过程中会服用多种药物,因此有必要开发新的药物一致性核对技术,这些技术不依赖于患者的记忆或知识,以改善患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2124/3118653/5e2d1262a14a/nihms275897f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2124/3118653/5e2d1262a14a/nihms275897f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2124/3118653/5e2d1262a14a/nihms275897f1.jpg

相似文献

1
Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care.在接受初级 HIV 护理的 HIV 感染者中,与医疗记录相比,自我报告当前和既往抗逆转录病毒药物使用情况。
Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):432-9. doi: 10.1002/pds.2096. Epub 2011 Feb 3.
2
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.HIV感染合并高血压或慢性肾脏病成人患者的疾病认知、用药信念以及对抗逆转录病毒药物和合并症用药的依从性
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):403-410. doi: 10.1097/QAI.0000000000001075.
3
The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries.五个非洲国家的艾滋病毒感染者报告的服用或不服用抗逆转录病毒药物对艾滋病毒污名化的影响。
AIDS Care. 2009 Nov;21(11):1357-62. doi: 10.1080/09540120902862576.
4
Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.南非广泛耐药结核病和 HIV 患者治疗中的依从性:一项前瞻性队列研究。
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):22-9. doi: 10.1097/QAI.0000000000000221.
5
Self-Reported adherence to antiretroviral treatment among HIV-infected people in Central China.中国中部地区HIV感染者自我报告的抗逆转录病毒治疗依从性
AIDS Patient Care STDS. 2008 Jan;22(1):71-80. doi: 10.1089/apc.2007.0047.
6
Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017.美国 HIV 感染者孕妇 2008-2017 年抗逆转录病毒药物处方实践
JAMA Netw Open. 2019 Dec 2;2(12):e1917669. doi: 10.1001/jamanetworkopen.2019.17669.
7
Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.老龄化 HIV 感染人群中,多种药物并用与抗逆转录病毒药物相互作用的风险。
J Gen Intern Med. 2013 Oct;28(10):1302-10. doi: 10.1007/s11606-013-2449-6. Epub 2013 Apr 20.
8
An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.里约热内卢一家公立诊所的抗逆转录病毒艾滋病毒/艾滋病治疗评估。
Trop Med Int Health. 2003 May;8(5):378-85. doi: 10.1046/j.1365-3156.2003.01046.x.
9
Compliance with clinical guidelines and adherence to antiretroviral therapy among patients living with HIV.HIV 感染者对临床指南的遵循情况及抗逆转录病毒治疗的依从性。
Curr Med Res Opin. 2019 Jan;35(1):63-71. doi: 10.1080/03007995.2018.1519499. Epub 2018 Sep 15.
10
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.赞比亚预防艾滋病毒母婴传播的抗逆转录病毒药物的长期依从性
BMC Pregnancy Childbirth. 2015 Oct 12;15:258. doi: 10.1186/s12884-015-0697-7.

引用本文的文献

1
Higher Clinician-Patient Communication Is Associated With Greater Satisfaction With HIV Care.医患沟通愈频繁,HIV 护理满意度愈高。
J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:23259582211054935. doi: 10.1177/23259582211054935.
2
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.产后单剂量替诺福韦酯/恩曲他滨不能预防在产前接受齐多夫定及产时接受单剂量奈韦拉平以预防母婴HIV-1传播的女性中出现非核苷类逆转录酶抑制剂耐药。
J Med Virol. 2015 Oct;87(10):1662-7. doi: 10.1002/jmv.24220. Epub 2015 May 4.
3

本文引用的文献

1
Questionnaire design and the recall of pharmacological treatments: a systematic review.问卷设计与药物治疗的回顾:一项系统综述
Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):175-87. doi: 10.1002/pds.1703.
2
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.在一项大型欧洲队列研究中对抗逆转录病毒治疗期间的HIV耐药性检测及临床进展情况
AIDS. 2008 Oct 18;22(16):2187-98. doi: 10.1097/QAD.0b013e328310e04f.
3
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.
HIV risk behaviors and sociodemographic features of HIV-infected Latinos residing in a new Latino settlement area in the Southeastern United States.
居住在美国东南部一个新的拉丁裔聚居区的感染艾滋病毒的拉丁裔人群的艾滋病毒风险行为及社会人口学特征。
AIDS Care. 2013;25(10):1298-307. doi: 10.1080/09540121.2013.764964. Epub 2013 Feb 5.
4
The state of disparities in opportunistic infection prophylaxis for blacks with HIV/AIDS.艾滋病毒/艾滋病患者中,黑人机会性感染预防的差距状况。
Med Care. 2012 Nov;50(11):920-7. doi: 10.1097/MLR.0b013e31826c85d1.
5
Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users.住院的感染艾滋病毒的快克可卡因使用者抗逆转录病毒药物使用情况的相关因素
AIDS Res Hum Retroviruses. 2012 Sep;28(9):1007-14. doi: 10.1089/AID.2011.0329. Epub 2012 Mar 2.
6
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study.每日一次替诺福韦酯(TDF)为基础的抗逆转录病毒治疗方案在接受阿片类药物治疗的 HIV-1 感染的前注射吸毒者中的疗效、依从性和耐受性:一项 48 周开放性研究的结果。
Eur J Med Res. 2011 Oct 10;16(10):427-36. doi: 10.1186/2047-783x-16-10-427.
7
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).达芦那韦/利托那韦联合拉替拉韦治疗初治 HIV-1 感染患者的疗效(ACTG A5262)。
AIDS. 2011 Nov 13;25(17):2113-22. doi: 10.1097/QAD.0b013e32834bbaa9.
在每日一次固定剂量联合抗逆转录病毒治疗时代,治疗方案的耐用性增强。
AIDS. 2008 Oct 1;22(15):1951-60. doi: 10.1097/QAD.0b013e32830efd79.
4
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.成人HIV感染的抗逆转录病毒治疗:美国国际艾滋病协会专家组2008年建议
JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.
5
Early experiences with personal health records.个人健康记录的早期经历。
J Am Med Inform Assoc. 2008 Jan-Feb;15(1):1-7. doi: 10.1197/jamia.M2562. Epub 2007 Oct 18.
6
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.TMC125(依曲韦林)在DUET-1研究中接受过治疗的HIV-1感染患者中的疗效和安全性:一项随机、双盲、安慰剂对照试验的24周结果
Lancet. 2007 Jul 7;370(9581):29-38. doi: 10.1016/S0140-6736(07)61047-2.
7
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.达芦那韦-利托那韦在POWER 1和2研究中对经治HIV-1感染患者48周时的疗效和安全性:两项随机试验数据的汇总亚组分析
Lancet. 2007 Apr 7;369(9568):1169-78. doi: 10.1016/S0140-6736(07)60497-8.
8
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.三联抗逆转录病毒药物耐药性:HIV-1感染患者中的风险及预测因素
AIDS. 2007 Apr 23;21(7):825-34. doi: 10.1097/QAD.0b013e32805e8764.
9
Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials.干预措施在提高高效抗逆转录病毒疗法依从性及HIV-1 RNA病毒载量方面的疗效。一项随机对照试验的荟萃分析综述
J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1(0 1):S23-35. doi: 10.1097/01.qai.0000248342.05438.52.
10
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.高效抗逆转录病毒疗法的依从性:对发达国家和发展中国家患者报告的障碍及促进因素的系统评价
PLoS Med. 2006 Nov;3(11):e438. doi: 10.1371/journal.pmed.0030438.